NURO

Our history.

NURO was launched on the basis that better solutions in healthcare are critically needed. Today, science needs technology and both need business acumen to become concrete deliverables. At NURO, we understand this key requirement for a multi-disciplinary approach to solving complex challenges and we have assembled some of the top experts in healthcare, science, advanced technologies, entrepreneurship and business globally to architect revolutionary products.

Our history has been marked by transformational events and numerous milestones on multiple continents. With your trust in us, we look forward to adding many more in the years to come.

2014

Alzheimer + Trauma Hit Home

2017

NURO is incorporated

2019

NURO gets regulatory clearances

2020

First product launched

Our investors.

SOSV VC
Dr. Kupfer
Dr. Laghrissi-Thode
OCE

SOSV is a global venture capital firm that invests in 150 companies every year through their world-class vertical accelerator programs. These intensive accelerators provide handpicked startups with significant seed capital and a specialized global staff to accelerate product development, mentors with deep market and technical expertise and an unparalleled infrastructure of fully outfitted laboratories and operational spaces in Silicon Valley and across the world. SOSV’s mission to support human and planetary health has today nearly 1,000 startups operating in 56 countries. SOSV’s programs, IndieBio and HAX, are based in San Francisco, New York City and Newark, supported by offshore design and engineering teams in Pune, India and Shenzhen, China. Everywhere, SOSV is helping founders go further, faster.

Our press coverage.

Special Live Coverage

NURO was streamed live on TechCrunch From San Francisco for INDIE BIO's Demo Day 2018. After almost 5 months, 14 companies graduated from what is considered the leading Life Science's Accelerator in the world. NURO, not only graduated with only its Founder and CEO on-location for the entire duration of the program, but also managed to grab the last famous "Killer Week" Award with an incredible live demonstration of NUOS for the first time.

Google Canada Selects NURO for its Inaugural Google Cloud Accelerator

Google's interests in healthcare and incredible tools to assist human kind are in harmony with both our own technological developments and our core philosophy. We are proud to be selected with 11 other firms for this incredible accelerator and very much look forward to establishing a strong and fruitful collaboration with Google, the Google developers and industry mentors.

This Neural Operating System Lets Paralyzed, Voiceless Patients communicate

For the first time, NUOS, the Neural Operating System got into the public spotlight. After hundreds of iterations, we had finally reached a viable architecture, a technical foundation, a platform which would allow our team to not only deliver a solution to highly incapacitated patients, their families, their doctors and caregivers but also allow us to keep on developing on our multimodal signal processing and ultimately deliver a first in its class when it comes to reliable assistive communication and non-invasive brain-to-computer interfacing.

You Can Control This New Software With Your Brain, And It Should Make Elon Musk And Mark Zuckerberg Nervous

An in-depth coverage was done by the highly-respected tech journalist, Erin Brodwin, on what NURO had accomplished in 2018 during our Silicon Valley residency. This was an important new validation for our team and a confirmation that our work was starting to be valuable to patients in need and certainly noticeable to the rest of the World and other significant efforts in the field of neurotechnology.

CTRL-Labs and NURO

CTRL-Labs was a firm specializing in neurotechnology, specifically, an enhanced electromyography system. Their team specialized in processing muscular signals from your wrist and was bought out by Meta for what is reported to be one billion dollars!

The iHuman Report: Blurring lines between Mind and Machine

The Royal Society is a Fellowship of many of the World's most eminent scientists and is the oldest scientific academy in existence. In this important publication, The Royal Society takes a deeper look into neural and brain-computer interfaces.

The Companies in Brain Computer Interfaces

Did you know that over $19 billion has been invested in Neurotech companies in the last 20 years ? This and much more can be found in this reference article about our industry. One can see an overview of the global NeuroTech landscape in 2020 with over 200 companies worldwide working on different areas such as NeuroModulation, NeuroImaging, NeuroPharmacology and ofcourse Brain Computer Interfaces in which NURO fits with 12 other firms.